%0 Conference Paper
%B The 2nd European Stroke Organisation Conference
%C Barcelona, Spain
%D 2016
%F AUS<br/>NMH<br/>FY16
%G eng
%T ENCHANTED Main Results - Trial of low-dose versus standard-dose intravenous tissue plasminogen activator in 3310 patients with acute ischaemic stroke [invited speaker]